Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in December 1999 by Yangzhou Pharmaceutical Factory, which was established in 1958. In March 2003, the company achieved an A-share listing. After years of reform, innovation and development, Jiangsu Lianhuan Pharmaceutical Co., Ltd. has grown into a national high-tech enterprise that integrates research and development, production, and sales. It is ranked among the top 100 enterprises in China's pharmaceutical industry and has achieved a series of development achievements. We have multiple subsidiaries including Yangzhou Lianhuan Pharmaceutical Marketing, Lianhuan (Nanjing) Medical Technology, Nanjing Lianzhi Pharmaceutical Technology, and Chengdu Yazhong Biopharmaceutical. At present, the company has formed two research and development platforms, Nanjing and Yangzhou, based on academician workstations and doctoral workstations. It has established good technical cooperation relationships with major institutions such as the Shanghai Institute of Pharmacy of the Chinese Academy of Sciences and the China Pharmaceutical University. So far, it has developed more than 10 national level new drugs, including national first class new drugs, and several generic drugs, and has obtained multiple invention patents. The company's products cover five major series: urinary system products (mainly including epristeride, terazosin and other varieties), antihistamines (mainly including ebastin tablets, terfenadine tablets and other varieties), cardiovascular products (mainly including felodipine tablets, simvastatin tablets and other varieties), steroid hormones (mainly including levonorgestrel, danazol capsules and other varieties), and antibiotics (mainly including azithromycin tablets, doxycycline hydrochloride tablets and other varieties). In recent years, Lianhuan Pharmaceutical has adhered to technological innovation, pursued green development, and focused on building a modern pharmaceutical enterprise. The company is vigorously sailing and accelerating on the new journey of "secondary entrepreneurship". |
| Headquarter | Yangzhou City |
| Establish Date | 2/22/2000 |
| Listed Code | 600513.SH |
| Listed Date | 3/19/2003 |
| Chairman | Wu Wenge. |
| CEO | Niu Ben. |
| Website | www.lhpharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
